Transcriptional factor HBP1 targets P16^INK4A, upregulating its expression and consequently is involved in Ras-induced premature senescenceLI, H; WANG, W; LIU, X et al.Oncogene (Basingstoke). 2010, Vol 29, Num 36, pp 5083-5094, issn 0950-9232, 12 p.Article

Delayed ageing through damage protection by the Arf/p53 pathwayMATHEU, Ander; MARAVER, Antonio; KLATT, Peter et al.Nature (London). 2007, Vol 448, Num 7151, pp 375-379, issn 0028-0836, 5 p.Article

Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursorsSOUFIR, N; QUEILLE, S; VILMER, C et al.British journal of dermatology (1951). 2007, Vol 156, Num 3, pp 448-453, issn 0007-0963, 6 p.Article

Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2AELNENAEI, Manal O; GRUSZKA-WESIWOOD, Alicja M; A'HERN, Roger et al.Haematologica (Roma). 2003, Vol 88, Num 5, pp 529-537, issn 0390-6078, 9 p.Article

Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15^INK4B tumor suppressor geneKOTAKE, Y; NAKAGAWA, T; KITAGAWA, K et al.Oncogene (Basingstoke). 2011, Vol 30, Num 16, pp 1956-1962, issn 0950-9232, 7 p.Article

TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradationPOLLICE, A; SEPE, M; VILLELLA, V. R et al.Oncogene (Basingstoke). 2007, Vol 26, Num 35, pp 5154-5162, issn 0950-9232, 9 p.Article

Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomasKAUNE, Kjell M; NEUMANN, Christine; HALLERMANN, Christian et al.Experimental dermatology. 2011, Vol 20, Num 4, pp 331-335, issn 0906-6705, 5 p.Article

ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1SATO, Kazuyuki; NAKAGAWA, Hiroki; TAJIMA, Atsushi et al.Oncology reports. 2010, Vol 24, Num 3, pp 701-707, issn 1021-335X, 7 p.Article

CDKN2A mutations in melanoma families from UruguayBORGES, A. L; CUELLAR, F; LAPORTE, M et al.British journal of dermatology (1951). 2009, Vol 161, Num 3, pp 536-541, issn 0007-0963, 6 p.Article

Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2MOHSENY, Alexander B; SZUHAL, Karoly; ROMEO, Salvatore et al.Journal of pathology (Print). 2009, Vol 219, Num 3, pp 294-305, issn 0022-3417, 12 p.Article

A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)HARLAND, Mark; GOLDSTEIN, Alisa M; HAYWARD, Nicholas K et al.European journal of cancer (1990). 2008, Vol 44, Num 9, pp 1269-1274, issn 0959-8049, 6 p.Article

Methylation of the p16^INK4a promoter region in telomerase immortalized human keratinocytes co-cultured with feeder cellsDARBRO, B. W; LEE, K. M; NGUYEN, N. K et al.Oncogene (Basingstoke). 2006, Vol 25, Num 56, pp 7421-7433, issn 0950-9232, 13 p.Article

Linkage and association analysis of nevus density and the region containing the melanoma gene CDKN2A in UK twinsBARRETT, J. H; GAUT, R; WACHSMUTH, R et al.British journal of cancer. 2003, Vol 88, Num 12, pp 1920-1924, issn 0007-0920, 5 p.Article

Somatic p16^INK4a loss accelerates melanomagenesisMONAHAN, K. B; ROZENBERG, G. I; KRISHNAMURTHY, J et al.Oncogene (Basingstoke). 2010, Vol 29, Num 43, pp 5809-5817, issn 0950-9232, 9 p.Article

Hematopoietic stem cell ageing is uncoupled from p16^INK4A-mediated senescenceATTEMA, J. L; PRONK, Cjh; NORDDAHL, G. L et al.Oncogene (Basingstoke). 2009, Vol 28, Num 22, pp 2238-2243, issn 0950-9232, 6 p.Article

Alterations in the p16^INK4a and p53 tumor suppressor genes of hTERT-immortalized human fibroblastsNOBLE, Jane R; ZHONG, Ze-Huai; NEUMANN, Axel A et al.Oncogene (Basingstoke). 2004, Vol 23, Num 17, pp 3116-3121, issn 0950-9232, 6 p.Article

Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/BCONGRAINS, Ada; KAMIDE, Kei; YAMAMOTO, Koichi et al.Atherosclerosis. 2012, Vol 220, Num 2, pp 449-455, issn 0021-9150, 7 p.Article

Iatrogenic melanoma. Comment on: Melanoma epidemic: a midsummer night's dream?VAN DER RHEE, J. I; MOOI, W. J; KUKUTSCH, N. A et al.British journal of dermatology (1951). 2010, Vol 162, Num 2, pp 457-458, issn 0007-0963, 2 p.Article

The Ink4/Arf locus is a barrier for iPS cell reprogrammingHAN LI; COLLADO, Manuel; VILLASANTE, Aranzazu et al.Nature (London). 2009, Vol 460, Num 7259, pp 1136-1139, issn 0028-0836, 4 p.Article

Restoration of CDKN2A into melanoma cells induces morphologic changes and reduction in growth rate but not anchorage-independent growth reversalCASTELLANO, M; GABRIELLI, B. G; HUSSUSSIAN, C. J et al.Journal of investigative dermatology. 1997, Vol 109, Num 1, pp 61-68, issn 0022-202XArticle

Aberrant de novo methylation of the p16^INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioningHINSHELWOOD, Rebecca A; MELKI, John R; HUSCHTSCHA, Lily I et al.Human molecular genetics (Print). 2009, Vol 18, Num 16, pp 3098-3109, issn 0964-6906, 12 p.Article

Downregulation of the tumour suppressor p16^INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)\-like phenotypeFUENTES, L; WOUTERS, K; PAUMELLE, R et al.Diabetologia (Berlin). 2011, Vol 54, Num 12, pp 3150-3156, issn 0012-186X, 7 p.Article

CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skinKÜSTERS-VANDEVELDE, Heidi V. N; VAN LEEUWEN, Arjanne; VERDIJK, Marian A. J et al.International journal of cancer (Print). 2010, Vol 126, Num 9, pp 2123-2132, issn 0020-7136, 10 p.Article

Novel and recurrent p14^ARF mutations in Italian familial melanomaBINNI, F; ANTIGONI, I; CATRICALA, C et al.Clinical genetics. 2010, Vol 77, Num 6, pp 581-586, issn 0009-9163, 6 p.Article

Page / 7